HK Peptides Ipamorelin
As of 9 Aug 2026, Finnrick has published 13 independent lab tests of Ipamorelin from HK Peptides: 7 passed and 6 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 26 Feb 2026. The current Finnrick rating for HK Peptides Ipamorelin is 58%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 26 Feb 2026 | Fail | Certificate ev9yauu |
| 20 Feb 2026 | Fail | Certificate npupga7 |
| 16 Feb 2026 | Fail | Certificate rzwb3dp |
| 11 Feb 2026 | Pass | Certificate 742cutx |
| 2 Feb 2026 | Fail | Certificate 2ha4kvs |
| 19 Jan 2026 | Pass | Certificate 287gpqw |
| 29 Dec 2025 | Fail | Certificate ffsdhph |
| 18 Dec 2025 | Pass | Certificate rw2pvg5 |
| 17 Dec 2025 | Pass | Certificate 27xeyyr |
| 2 Dec 2025 | Pass | Certificate 2tkcw6r |
| 4 Nov 2025 | Fail | Certificate pnyr8qr |
| 21 Oct 2025 | Pass | Certificate szng3sp |
| 21 Aug 2025 | Pass | Certificate gnnjv53 |